Results 161 to 170 of about 805,931 (288)

La nicotinamide topica nel trattamento dell'acne

, 2008
R. Schianchi, S. Veraldi, Italian Acne Board   +2 more
core   +2 more sources

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern, Simon Francis Thomsen, Georgios Kokolakis, Maurizio Podda, Gregor B. E. Jemec, Kurt Gebauer, Claus Zachariae, John Frew, Pablo Fernandez‐Peñas, Falk G. Bechara, Stefan Beissert, Sourabh Malandkar, Karen Scalzo‐Inguanti, Partha Nandy, Selvakumar Sukumar   +14 more
wiley   +1 more source

A Correlation between Serum Level of Alkaline Phosphatase and Acne Severity in Children and Adolescents: A Retrospective Cross-Sectional Study. [PDF]

Ann Dermatol, 2020
Jue MS, Park E, Kang HS, Kim JS.
europepmc   +1 more source

Endocrine and nutritional aspects in women with acne vulgaris.

reservedL'Acne Vulgaris è una malattia dermatologica infiammatoria cronica che coinvolge l'unità pilosebacea della cute. È una patologia ad elevata prevalenza nella popolazione generale che può causare cicatrici, deturpazione e disagio ...
GASPARONI, ANNA
core  

Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In adults with moderate AD post‐TCS and ‐TCI, who may otherwise be eligible for systemic therapy, 1.5% ruxolitinib cream improved clinical signs and symptoms in the TRuE‐AD4 study. Abstract Background In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently ...
José Manuel Carrascosa, Vimal H. Prajapati, H. Chih‐ho Hong, Viktoria Eleftheriadou, Athanasios Tsianakas, Alexander A. Navarini, Ketty Peris, Eingun James Song, Raj Chovatiya, Sébastien Barbarot, Konstantin Popovic, Haq Nawaz, Qian Li, Vivek Purohit, Andreas Wollenberg   +14 more
wiley   +1 more source

Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic Fibrosis. [PDF]

J Cosmet Dermatol
Smith AD, Lyons CE, Somerville L, Flowers RH, Kaplan E, Albon D.   +5 more
europepmc   +1 more source

Beyond weight loss: Preserving muscle health in the incretin era

Journal of Diabetes Investigation, EarlyView.
Toshinori Imaizumi, Daisuke Yabe
wiley   +1 more source

Measuring success in HS treatment from the physician's and the patient's perspective

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis, Monika Arenbergerova, Zeljko Mijuskovic, Baoxi Wang, Christos C. Zouboulis   +4 more
wiley   +1 more source

Deep Learning-Based Acne Severity Classification Using Standardized Facial Images of Japanese Patients. [PDF]

Cureus
Watanabe K, Iinuma K, Nakashima C, Yamamoto H, Oiso N, Otsuka A.   +5 more
europepmc   +1 more source

Effectiveness of Standard Therapy for Acne Vulgaris Based on Clinical Practice Guidelines in Indonesia [PDF]

Maria Clarissa Wiraputranto,1 Irma Bernadette S Sitohang,1 Adhimukti Tathyahita Sampurna,1 Muhammad Ilyas2 1Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr.
Wiraputranto MC, Ilyas M, Sitohang IBS, Sampurna AT   +3 more
core